Clinical Trial Update: Clinical Trial to Evaluate the Safety and Tolerability of Hydrogen in Patients With Parkinson's Disease [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating safety and tolerability of hydrogen in Parkinson's disease was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Stony Brook University | Conditions: Parkinson Disease | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2023-04-12